The impact of alcohol use severity on anxiety treatment outcomes in a large effectiveness trial in primary care

Journal of Anxiety Disorders

Volumn 30, Issue , 2015, Pages 88-93

  Wolitzky Taylor, Kate ^a   Brown, Lily A ^b   Roy Byrne, Peter ^c   Sherbourne, Cathy ^d   Stein, Murray B ^e   Sullivan, Greer ^f,g   Bystritsky, Alexander ^b   Craske, Michelle G ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d RAND CORPORATION   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f South Central VA Mental Illness Research Education and Clinical Center   (United States)

^g UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Alcohol use; Anxiety disorders; Predictors of treatment outcome

Indexed keywords

ANXIOLYTIC AGENT;

ADULT; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ANXIETY DISORDER; ANXIETY SENSITIVITY INDEX; ARTICLE; BRIEF SYMPTOM INVENTORY; CLINICAL EFFECTIVENESS; COGNITIVE THERAPY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT HEALTH QUESTIONNAIRE 8; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; ALCOHOLISM; ANXIETY DISORDERS; CONTROLLED STUDY; DRINKING BEHAVIOR; MULTIMODALITY CANCER THERAPY; PRIMARY HEALTH CARE; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALCOHOL DRINKING; ALCOHOL-RELATED DISORDERS; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; PRIMARY HEALTH CARE; TREATMENT OUTCOME;

EID: 84921478421     PISSN: 08876185     EISSN: 18737897     Source Type: Journal    
DOI: 10.1016/j.janxdis.2014.12.011     Document Type: Article

References (50)

1. Adams W.L., Barry K.L., Fleming M.F. Screening for problem drinking in older primary care patients. The Journal of American Medical Association 1996, 68:378-388.
2. Aiken L.S., West S.G. Multiple regression testing and interpreting interactions 1991, SAGE Publications, Thousand Oaks, CA.
3. Arch J.J., Ayers C.R. Which treatment worked better for whom: moderators of group cognitive behavioral therapy versus adapted mindfulness based stress reduction for anxiety disorders. Behaviour Research and Therapy 2013, 51:434-442.
4. Archer L., Grant B.F., Dawson D.A. What if Americans drank less: the potential effect on the prevalence of alcohol abuse and dependence. American Journal of Public Health 1995, 85:61-66.
5. Babor T.F., Higgins-Biddle J.C., Saunders J.B., Monteiro M.G. The alcohol use disorders identification test: guidelines for use in primary care 2001, World Health Organization: Department of Mental Health and Substance Dependence, Geneva, Switzerland. Second ed.
6. Babor T.F., McRee B.G., Kassebaum P.A., Grimaldi P.L., Ahmed K., Bray J. Screening, brief intervention, and referral to treatment (SBIRT). Substance Abuse 2007, 3:7-30.
7. Bakken K., Landheim A.S., Vaglum P. Substance-dependent patients with and without social anxiety disorder: occurrence and clinical differences: a study of a consecutive sample of alcohol-dependent and poly-substance-dependent patients treated in two counties in Norway. Drug and Alcohol Dependence 2005, 80:321-328.
8. Bakken K., Landheim A.S., Vaglum P. Axis I and II disorders as long-term predictors of mental distress: a six-year prospective follow-up of substance-dependent patients. BMC Psychiatry 2007, 7.
9. Barry C.L., Huskamp H.A. Moving beyond parity- mental health and addiction care under the ACA. The New England Journal of Medicine 2011, 365:973-975.
10. Brown P.J., Stout R.L., Mueller T. Substance use disorder and posttraumatic stress disorder comorbidity: addiction and psychiatric treatment rates. Psychology of Addictive Behaviors 1999, 13:115-122.
11. Bruce S.E., Yonkers K.A., Otto M.W., Eisen J.L., Weisberg R.B., Pagano M., et al. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. American Journal of Psychiatry 2005, 162:1179-1187.
12. Conger J.J. Alcoholism theory, problem and challenge: reinforcement theory and the dynamics of alcoholism. Quarterly Journal of Studies on Alcohol 1956, 13:296-305.
13. de Kleine R.A., Hendriks G., Smits J.A.J., Broekman T.G., van Minnen A. Prescriptive variables for d-cycloserine augmentation of exposure therapy for posttraumatic stress disorder. Journal of Psychiatric Research 2014, 48:40-46.
14. Derogatis L.R. BSI Brief Symptom Inventory: administration, scoring, and procedure manual 1993, National Computer Systems, Minneapolis, MN. Fourth ed.
15. Derogatis L.R. Symptom Checklist-90-R (SCL-90-R): administration, scoring, and procedures manual 1994, NCS, Minneapolis, MN.
16. Derogatis L.R., Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychological Medicine 1983, 13:595-605.
17. Dybek I., Bischof G., Grothues J., Reinhardt S., Meyer C., Hapke U., et al. The Reliability and Validity of the Alcohol Use Disorders Identification Test (AUDIT) in a German general practice population sample. Journal of Studies on Alcohol 2006, 67:473-481.
18. Fals-Stewart W., Angarano K. Obsessive-compulsive disorder among patients entering substance abuse treatment: prevalence and accuracy of diagnosis. Journal of Nervous and Mental Disease 1994, 182:715-719.
19. Gache P., Michaaud P., Landry U., Accietto C., Arfaoui S., Wenger O., et al. The Alcohol Use Disorders Identification Test (AUDIT) as a screening tool for excessive drinking in primary care: reliability and validity of a French version. Alcoholism: Clinical and Experimental Research 2005, 29:2001-2007.
20. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 2004, 61:807-816.
21. Greeley J., Oei T. Alcohol and tension reduction. Psychological theories of drinking and alcoholism 1999, Guilford Press, New York, NY. K.E. Leonard, H.T. Blane (Eds.).
22. Havassy B.E., Alvidrez J., Mericle A.A. Disparities in use of mental health and substance abuse services by persons with co-occurring disorders. Psychiatric Services 2009, 60:217-223.
23. Hilton M.E. Drinking patterns and drinking problems in 1984: results from a general population survey. Alcoholism: Clinical and Experimental Research 1987, 11:167-175.
24. Hingson R.W., Zha W. Age of drinking onset, alcohol use disorders, frequent heavy drinking, and unintentionally injurying oneself and others after drinking. Pediatrics 2009, 123:1477-1484.
25. Khantzian E.J. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. American Journal of Psychiatry 1985, 142:1259-1264.
26. Kroenke K., Spitzer R.L., Williams J.B.W. The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine 2001, 16:601-613.
27. Kushner M., Donahue C., Sletten S., Thuras P., Abrams K., Peterson J., et al. Cognitive behavioral treatment of comorbid anxiety disorder in alcoholism treatment patients: presentation of a prototype program and future directions. Journal of Mental Health 2006, 15:697-707.
28. Kushner M., Krueger R., Frye B., Peterson J. Epidemiological perspectives on co-occurring anxiety disorder and substance use disorder. Anxiety and substance use disorders 2008, Springer Publisher, New York, NY. A.L. Stewart, P.J. Conrod (Eds.).
29. McGovern M.P., Xie H., Segal S.R., Siembab L., Drake R.E. Addiction treatment services and co-occurring disorders: prevalence estimates, treatment practices, and barriers. Journal of Substance Abuse Treatment 2006, 31:267-275.
30. Najavits L.M. Seeking safety: therapy for trauma and substance abuse. Corrections Today 2002, 64:136-141.
31. Norman S.B., Cissell S.H., Means-Christensen A.J., Stein M.B. Development and validation of an overall anxiety severity and impairment scale (OASIS). Depression and Anxiety 2006, 12:245-249.
32. Otto M.W., Pollack M.H., Sachs G.S., O'Neil C.A., Rosenbaum J.F. Alchohol dependence in panic disorder patients. Journal of Psychiatric Research 1992, 26:29-38.
33. Pating D.R., Miller M.M., Goplerud E., Martin J., Ziedonis D.M. New systems of care for substance use disorders: treatment, finance, and technology under health care reform. Psychiatric Clinics of North America 2012, 35:327-356.
34. Peterson R.A., Heilbronner R.L. The anxiety sensitivity index: construct validity and factor analytic structure. Journal of Anxiety Disorders 1987, 1:117-121.
35. Patient Protection and Affordable Care Act, 2010 (March 23, 2010).
36. Raudenbush S.W., Bryk A.S., Congdon R. HLM 6 for Windows 2004, Scientific Software International, Inc., Skokie, IL.
37. Reid M.C., Fiellin D.A., O'Connor P.G. Hazardous and harmful alcohol consumption in primary car. The Journal of the American Medical Association Internal Medicine 1999, 159:1681-1689.
38. Reiss S., Peterson R.A., Gursky D.M., McNally R.J. Anxiety sensitivity, anxiety frequency, and the prediction of fearfulness. Behavior Research and Therapy 1986, 24:1-8.
39. Roy-Byrne P., Craske M.G., Sullivan G., Rose R.D., Edlund M.J., Lang A.J., et al. Delivery of evidence-based treatment for multiple anxiety disorders in primary care. The Journal of the American Medical Association 2010, 303(19):1921-1928.
40. Sheehan D.V., Lecrubier Y., Sheehan K.H., Janavs J., Weiller E., Keskiner A., et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. European Psychiatry 1997, 12:232-241.
41. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M. I. N. I.): the development and validation of a structures diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 1998, 20(59 Supplement):22-33.
42. Smith J.P., Book S.W. Comorbidity of generalized anxiety disorder and alcohol use disorders among individuals seeking outpatient substance abuse treatment. Addictive Behavior 2010, 35:42-45.
43. Smits J.A., Powers M.B.C., Telch Y. Mechanism of change in cognitive-behavioral treatment of panic disorder: evidence for the fear of fear mediational hypothesis. Journal of Consulting and Clinical Psychology 2004, 72:646-652.
44. Smits J.A., Rosenfield D., Otto M.W., Powers M.B., Hofmann S.G., Telch M.J., et al. D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia. Biological Psychiatry 2013, 73:1054-1058.
45. Spitzer R.L., Williams J.B.W., Gibbon M., First M.B. Structured clinical interview for DSM-III-R, patent edition/non-patient edition (SCID-P/SCID-NP) 1990, American Psychiatric Press, Inc., Washington, DC.
46. Stewart S.H., Conrod P. Anxiety and substance use disorders: the vicious cycle of comorbidity 2008, Springer, New York, NY.
47. Volk R.J., Cantor S.B., Steinbauer J.R., Cass A.R. Alcohol use disorders, consumption patterns, and health-related quality of life in primary care patients. Alcoholism: Clinical and Experimental Research 1997, 21:899-905.
48. Wolitzky-Taylor, Arch J.J., Rosenfield D., Craske M.G. Moderators and non-specific predictors of treatment outcome for anxiety disorders: a comparison of cognitive behavioral therapy to acceptance and commitment therapy. Journal of Consulting and Clinical Psychology 2012, 80:786-799.
49. Wolitzky-Taylor K., Operskalski J., Ries R., Craske M.G., Roy-Byrne P. Understanding and treating comorbid anxiety disorders in substance users: review and future directions. Journal of Addiction Medicine 2011, 5:233-247.
50. Ziedonis D.M. Integrated treatment of co-occurring mental illness and addiction: clinical intervention, program, and system perspectives. CNS Spectrums 2004, 9:892-904.